Table 3.
Estimated unadjusted odds ratios (OR) using multivariate logistic regression analysis HIV screening test
| HIV screening Declining N (%) |
HIV screening Accepting N (%) |
ORb (95 % CI) | P value | |
|---|---|---|---|---|
| Gender | 364 (70) | 155 (30) | ||
| Male | 280 (77) | 93 (60) | 0.89 (0.69–1.08) | 0.215 |
| Female | 84 (23) | 62 (40) | 2.36 (2.09–3.01) | 0.047 |
| Being tested previouslya | 223 (70) | 95 (30) | ||
| Less than 3 months | 100 (44.8) | 25 (26.3) | 2.42 (2.11–2.87) | 0.001 |
| More than 3 months | 123 (55.2) | 70 (73.4) | 0.93 (0.73–1.01) | 0.109 |
| Identifiable risk for HIV infectionc | 364 (70) | 155 (30) | ||
| Yes | 250 (68.7) | 97 (62.6) | 1.88 (1.19–2.11) | 0.060 |
| No | 114 (31.3) | 58 (37.4) | 0.94 (0.77–0.99) | 0.271 |
Data from this table refers to the 519 respondents who completed the questionnaire
aThe data refers only to those who reported being screened for HIV at any time in their lives. 201 were never screened for HIV and are not shown
bThe reference group was ‘HIV screening—declining’. The coefficient estimated indicated likelihood of accepting the HIV screening
cIncluded all 519 respondents including those who reported having had unprotected intercourse and/or using of intravenous drugs for the past 3 months